New Agents and Techniques for Imaging Prostate Cancer

Journal of Nuclear Medicine

Martin G. Pomper¹  Atif Zaheer¹  Steve Y. Cho¹ 

[1] Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland

关键词: molecular imaging;    MRI;    PET;    SPECT;    radiopharmaceutical;   

DOI  :  10.2967/jnumed.109.061838

学科分类：医学（综合）

来源: Society of Nuclear Medicine

【 摘 要 】

The successful management of prostate cancer requires early detection, appropriate risk assessment, and optimum treatment. An unmet goal of prostate cancer imaging is to differentiate indolent from aggressive tumors, as treatment may vary for different grades of the disease. Different modalities have been tested to diagnose, stage, and monitor prostate cancer during therapy. This review briefly describes the key clinical issues in prostate cancer imaging and therapy and summarizes the various new imaging modalities and agents in use and on the horizon.

【 授权许可】

Unknown